CENTAURI THERAPEUTICS LIMITED

Active London

Other service activities n.e.c.

12 employees website.com
Life sciences and medical technology Other service activities n.e.c.
C

CENTAURI THERAPEUTICS LIMITED

Other service activities n.e.c.

Founded 6 Feb 2014 Active London, United Kingdom 12 employees website.com
Life sciences and medical technology Other service activities n.e.c.

Previous Company Names

ALTERMUNE LIMITED 2 Mar 2015 — 23 Dec 2015
ALTERMET LIMITED 6 Feb 2014 — 2 Mar 2015
Accounts Submitted 29 Sept 2025 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 21 Feb 2026 Next due 20 Feb 2027 8 months remaining
Net assets £7M £3M 2024 year on year
Total assets £7M £3M 2024 year on year
Total Liabilities £324K £134K 2024 year on year
Charges 1
1 satisfied

Contact & Details

Contact

Registered Address

First Floor 5 Fleet Place London EC4M 7RD United Kingdom

Telephone

0800 000 0000

Website

www.example.com

Full company profile for CENTAURI THERAPEUTICS LIMITED (08879741), an active life sciences and medical technology company based in London, United Kingdom. Incorporated 6 Feb 2014. Other service activities n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type small
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

£5.10M

Decreased by £4.18M (-45%)

Net Assets

£6.70M

Decreased by £3.31M (-33%)

Total Liabilities

£323.91k

Increased by £134.13k (+71%)

Turnover

N/A

Employees

12

Increased by 2 (+20%)

Debt Ratio

5%

Increased by 3 (+150%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 6

Investors (7)

Investor NameInvestor SinceParticipating Rounds
Investor 1Dec 2015Seed
Investor 4Feb 2022Series A
Investor 5Feb 2022Series A

Share Capital

Share Capital

Share allotments and capital structure

39 Allotments 276,480 Shares £34.58m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
8 Jan 202651,220£6.00m£117.14
10 Feb 202576,665£8.98m£117.14
10 Jul 202376,665£8.98m£117.14
26 Jan 2022952£100k£105.43
26 Jan 202250,256£5.89m£117.14

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (29)

Boehringer Ingelheim Venture Fund Gmbh
20.7%
67,343
Novo Holdings A/s
20.7%
67,343

Persons with Significant Control

Persons with Significant Control (0)

0 Active 1 Ceased

Lak Holdings Llp

Ceased 18 Jul 2023

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

1 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
21 Feb 2026Confirmation StatementConfirmation statement made on 6 Feb 2026 with updates
30 Jan 2026IncorporationMemorandum Articles
30 Jan 2026ResolutionResolutions
15 Jan 2026OfficersAppointment of Henni-Karoliina Ropponen as director on 7 Jan 2026
15 Jan 2026CapitalAllotment of shares (GBP 783.362832) on 8 Jan 2026
21 Feb 2026 Confirmation Statement

Confirmation statement made on 6 Feb 2026 with updates

30 Jan 2026 Incorporation

Memorandum Articles

30 Jan 2026 Resolution

Resolutions

15 Jan 2026 Officers

Appointment of Henni-Karoliina Ropponen as director on 7 Jan 2026

15 Jan 2026 Capital

Allotment of shares (GBP 783.362832) on 8 Jan 2026

Recent Activity

Latest Activity

Confirmation statement made on 6 Feb 2026 with updates

3 months ago on 21 Feb 2026

Memorandum Articles

4 months ago on 30 Jan 2026

Resolutions

4 months ago on 30 Jan 2026

Appointment of Henni-Karoliina Ropponen as director on 7 Jan 2026

4 months ago on 15 Jan 2026

Allotment of shares (GBP 783.362832) on 8 Jan 2026

4 months ago on 15 Jan 2026